GlassScriptPhysician profile
Mary A Gordy
NPI 1124167325
$3,933.96
in general payments reported to CMS, 2019-2025
33 companies · $712 in 2025
The $712 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $737 · 2022: $783 · 2023: $727 · 2024: $975 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,414.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $419.43 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $417.68 | 2021-2024 | |
| Edwards Lifesciences Corporation | $392.28 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $324.77 | 2021-2023 | Farxiga |
| Revance Therapeutics, INC. | $316.06 | 2024-2025 | Daxxify, Daxi |
| Atricure, INC. | $274.12 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Medtronic, INC. | $246.33 | 2022-2024 | Endurant Iis |
| Inspire Medical Systems, INC. | $227.23 | 2023-2025 | Inspire |
| Boston Scientific Corporation | $208.16 | 2023-2025 | Watchman, Ranger, Enroute Transcarotid Neuroprotection System |
| Stryker Corporation | $174.62 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $130.00 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $91.62 | 2022-2024 | Camzyos, Eliquis |
| Pfizer INC. | $85.10 | 2022-2025 | |
| Esperion Therapeutics, INC. | $80.47 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.96 | 2021-2025 | Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $43.50 | 2025 | |
| La Jolla Pharmaceutical Company | $36.25 | 2024-2025 | Giapreza |
| Merck Sharp & Dohme LLC | $35.63 | 2022-2023 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $35.42 | 2023-2024 | Inpefa |
| W. L. Gore & Associates, INC. | $34.55 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Terumo Medical Corporation | $33.57 | 2022 | |
| Baxter Healthcare | $31.39 | 2025 | Tisseel |
| Innovation Technologies INC | $31.36 | 2025 | Irrisept |
| Chiesi USA, INC. | $29.37 | 2024 | Cleviprex, Kengreal |
| Solventum Corporation | $25.50 | 2025 | Prevena |
| Lemaitre Vascular, INC. | $25.29 | 2025 | Artegraft Vascular Graft |
| Galderma Laboratories, L.P. | $22.38 | 2024 | Dysport |
| Daiichi Sankyo INC. | $18.85 | 2024 | Injectafer |
| Abbott Laboratories | $18.44 | 2022 | |
| Novo Nordisk INC | $15.17 | 2023 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals, LTD. | $14.07 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.55 | 2023 | Uptravi, Opsumit |
| Zimmer Biomet Holdings, INC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Gordy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.